DETERMINANTS IN PLATELET MICROBICIDAL PROTEINS
血小板杀菌蛋白的决定因素
基本信息
- 批准号:6751207
- 负责人:
- 金额:$ 33.95万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-07-01 至 2007-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (Adapted from the Applicant's Abstract): Human and rabbit
platelets contain platelet microbicidal proteins (PMPs). The investigators'
data show that PMPs play key roles in platelet antimicrobial functions. PMPs
exert potent microbicidal actions against antibiotic-resistant bloodstream
pathogens, including Staphylococcus aureus and Candida albicans. Specific PMPs
are released from platelets exposed to pathogens or agonists at sites of
endovascular infection, and intensify locally at these sites. PMP-susceptible
pathogens are less virulent in animal models than their isogenic PMP-resistant
counterparts. These compelling facts support their hypothesis that PMPs
significantly contribute to antimicrobial host defense. PMPs are minimally
toxic to human vascular endothelial cells or erythrocytes, and differ markedly
in structure and mechanism from antimicrobial peptides that are not released
into the bloodstream. These facts suggest PMPs have key functional determinants
that optimize microbicidal activity without concomitant host cytotoxicity.
Beyond its microbicidal effects, they have discovered that PMP-2 also
potentiates neutrophil chemotaxis, phagocytosis and intracellular killing of S.
aureus. PMP-2 has a cystine-X-cystine (CXC) motif distinctive of
alpha-chemokines such as human platelet factor-4 (hPF-4) that amplify
antimicrobial mechanisms of neutrophils. These facts indicate that PMP-2 is a
unique molecule that exerts both direct microbicidal and
neutrophil-potentiating effects. The investigators' central hypothesis contends
that PMP-2 has specific determinants responsible for these distinct host
defense functions. They further hypothesize these determinants can be defined,
modeled, and used to establish key structure-activity relationships (SARs)
governing specific functions. The proposed studies are designed to explore
these hypotheses. Defining SARs in PMP-2 functional determinants is crucial to
their eventual goal of designing anti-infective agents with potent and/or
selective activity against antibiotic-resistant pathogens. Therefore, their
Specific Aims are: i) to define the structural determinants responsible for
direct microbicidal functions of PMP-2; ii) define the PMP-2 structural
determinants that potentiate the antimicrobial functions of neutrophils; and
iii) establish the key SARs in antimicrobial determinants of PMP-2. Comparison
of PMP-2 and hPF-4 determinants responsible for their potent and/or
discriminative antimicrobial functions will enable future studies of human PMPs
in the rabbit model that cannot be conducted in humans. Moreover, SAR themes
discovered in PMP-2 will accelerate discovery of novel anti-infective
strategies against pathogens resistant to conventional agents. Thus, these
studies will significantly advance our understanding of antimicrobial host
defense, and may yield new modes for its amplification.
描述(改编自申请人摘要):人和兔
血小板含有血小板杀微生物蛋白(PMP)。调查人员的
数据显示PMPs在血小板抗微生物功能中起关键作用。PMPs
对耐药性血流发挥有效的杀菌作用
病原体,包括金黄色葡萄球菌和白色念珠菌。特异性PMP
从暴露于病原体或激动剂的血小板中释放,
血管内感染,并在这些部位局部加重。PMP敏感
病原体在动物模型中的毒性低于其同基因PMP抗性
同行这些令人信服的事实支持他们的假设,
显著有助于抗微生物宿主防御。PMP最低限度
对人血管内皮细胞或红细胞有毒性,
在结构和机制上,
进入血液这些事实表明,PMP具有关键的功能决定因素
其优化了杀微生物活性而没有伴随宿主细胞毒性。
除了杀菌作用,他们还发现PMP-2还
增强嗜中性粒细胞的趋化性、吞噬作用和胞内杀伤S.
金黄色。PMP-2具有胱氨酸-X-胱氨酸(CXC)基序,
α-趋化因子如人血小板因子-4(HPF-4),
中性粒细胞的抗菌机制。这些事实表明,PMP-2是一种
独特的分子,发挥直接杀微生物和
嗜中性粒细胞增强作用。研究人员的核心假设认为,
PMP-2具有特定决定因素,
防御功能。他们进一步假设这些决定因素可以被定义,
建模,并用于建立关键结构-活性关系(SAR)
管理具体职能。拟议的研究旨在探索
这些假设。在PMP-2功能决定因子中定义SAR对于
他们的最终目标是设计具有强效和/或
对耐药性病原体的选择性活性。因此双方的
具体目标是:(一)确定结构决定因素,
PMP-2的直接杀微生物功能; ii)定义PMP-2的结构
增强嗜中性粒细胞抗菌功能的决定因素;以及
iii)建立PMP-2抗菌决定簇的关键SAR。比较
PMP-2和hPF-4决定因素负责其有效和/或
区别性的抗菌功能将使未来的研究人类PMPs
在兔子模型中进行,而这在人类中是无法进行的。此外,SAR主题
在PMP-2中发现的新基因将加速新型抗感染药物的发现
针对对常规药剂具有抗药性的病原体的战略。因此这些
这些研究将极大地促进我们对抗菌宿主的理解,
防御,并可能产生新的模式,其放大。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Efficacy of synthetic peptides RP-1 and AA-RP-1 against Leishmania species in vitro and in vivo.
合成肽 RP-1 和 AA-RP-1 对利什曼原虫的体外和体内功效。
- DOI:10.1128/aac.05349-11
- 发表时间:2012
- 期刊:
- 影响因子:4.9
- 作者:Erfe,MarieCriselB;David,ConsueloV;Huang,Cher;Lu,Victoria;Maretti-Mira,AnaClaudia;Haskell,Jacquelyn;Bruhn,KevinW;Yeaman,MichaelR;Craft,Noah
- 通讯作者:Craft,Noah
Emerging themes and therapeutic prospects for anti-infective peptides.
- DOI:10.1146/annurev-pharmtox-010611-134535
- 发表时间:2012-01
- 期刊:
- 影响因子:12.5
- 作者:N. Yount;M. Yeaman
- 通讯作者:N. Yount;M. Yeaman
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael R Yeaman其他文献
Michael R Yeaman的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael R Yeaman', 18)}}的其他基金
Systems Epigenomics of Persistent Bloodstream Infection
持续性血流感染的系统表观基因组学
- 批准号:
10551703 - 财政年份:2023
- 资助金额:
$ 33.95万 - 项目类别:
Epigenomic Mechanisms & Contextual Immunity in Persistent MRSA Bacteremia
表观基因组机制
- 批准号:
10551708 - 财政年份:2023
- 资助金额:
$ 33.95万 - 项目类别:
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection
抗生素持续性 MRSA 感染的系统免疫学
- 批准号:
9246423 - 财政年份:2016
- 资助金额:
$ 33.95万 - 项目类别:
Systems Immunolobiology of Antibiotic-Persistent MRSA Infection
抗生素持续性 MRSA 感染的系统免疫学
- 批准号:
9108773 - 财政年份:2016
- 资助金额:
$ 33.95万 - 项目类别:
Novel Context-Activated Protide Anti-Infectives
新型环境激活蛋白肽抗感染药
- 批准号:
7218790 - 财政年份:2007
- 资助金额:
$ 33.95万 - 项目类别:
Novel Context-Activated Protide Anti-Infectives
新型环境激活蛋白肽抗感染药
- 批准号:
7429814 - 财政年份:2007
- 资助金额:
$ 33.95万 - 项目类别:
相似海外基金
Defining the Correlates of Bactericidal Immunity in Tuberculosis
定义结核病杀菌免疫的相关性
- 批准号:
8031491 - 财政年份:2011
- 资助金额:
$ 33.95万 - 项目类别:
Defining the Correlates of Bactericidal Immunity in Tuberculosis
定义结核病杀菌免疫的相关性
- 批准号:
8207834 - 财政年份:2011
- 资助金额:
$ 33.95万 - 项目类别:














{{item.name}}会员




